CAS: 129-46-4; Sodium 8,8'-((3,3'-((3,3'-(Carbonylbis(Azanediyl))Bis(Benzoyl))Bis(Azanediyl))Bis(4-Methylbenzoyl))Bis(Azanediyl))Bis(Naphthalene-1,3,5-Trisulfonate)

上下游产品

CAS号10397-30-5 4-甲基-3-硝基苯甲酰氯

专利信息

专利号:US-9522932-B2
优先权日:2004-03-04
标 题 :Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
发明人：HERDEWIJN PIET; PANNECOUQUE CHRISTOPHE; WU TONGFEI; DE CLERCQ ERIK
权利人:LEUVEN K U RES & DEV
摘要:The invention is directed to a process for the preparation of substituted threonolactone and substituted threose compounds which are intermediates in the synthesis of phosphonate nucleosides being useful antiviral agents.

专利号:US-10335382-B2
优先权日:2013-06-14
标 题:Use of hydrogen sulfide synthesis inhibitors for cancer therapy
发明人：HELLMICH MARK; ZHOU JIA; SZABO CSABA
权利人:HELLMICH MARK; ZHOU JIA; SZABO CSABA; UNIV TEXAS
摘要:In certain aspects the methods comprise administering an inhibitor of hydrogen sulfide biosynthesis, a cystathionine-β-synthase (CBS) inhibitor, or a hydrogen sulfide neutralizing agent to a patient having a cancer associated with elevated production of hydrogen sulfide.

专利号:US-7572579-B2
优先权日:2004-02-27
标 题:Screening method for a ribonuclease H inhibitor of a reverse transcriptase
发明人：YOSHINAGA TOMOKAZ; SHISHIDO TAKAO
权利人:SHIONOGI & CO
摘要:A screening method for a compound which inhibits a ribonuclease H activity of a reverse transcriptase which includes incubating a substrate with an appropriate primer hybridized to an appropriate template, a metal ion and a reverse transcriptase to form a complex, adding a test substance, and after these steps adding dNTPs to initiate DNA synthesis, measuring the amount of nucleic acid cleaved from the template, and comparing the measured value with a measured value in the absence of a test substance.

专利号:US-5670130-A
优先权日:1989-08-09
标 题 :Zeolite L preparation
发明人：VERDUIJN JOHANNES P
权利人:EXXON CHEMICAL PATENTS INC ECP
摘要:Zeolite L containing caesium having enhanced catalytic properties is prepared by a process in which said zeolite L is crystallized from a synthesis mixture with a molar composition (expressed as oxides) of: - K2O/SiO2 0.22 to 0.30 - K2O/Cs2O 5 to 12 - H2O/K2O 50 to 90 - and - SiO2/Al2O3 6.0 to 7.0 - and containing 0.5 to 20 ppm (by weight) of divalent metal cations, e.g. Mg ions. The zeolite L can form part of a dehydrocyclization and/or isomerisation catalyst.

专利号:US-2019336462-A1
优先权日:2013-06-14
标题 :Use of hydrogen sulfide synthesis inhibitors for cancer therapy

专利号:US-2016095831-A1
优先权日:2013-06-14
标 题:Use of hydrogen sulfide synthesis inhibitors for cancer therapy